cefixime has been researched along with Urinary Tract Infections in 72 studies
Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.
Urinary Tract Infections: Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This study compares efficacy and safety of cefixime with amoxycillin + clavulanic acid in urinary tract infections." | 9.08 | [Comparative study of cefixime versus amoxicillin-clavulanic acid combination in the oral treatment of urinary tract infections in children]. ( Bost, C; Croizé, J; François, P; Wollschlager, K, 1995) |
| "The pharmacokinetics of cefixime, a third-generation broad-spectrum cephalosporin, were determined following administration of a 8 mg/kg single oral dose of cefixime suspension to six children with urinary tract infections, ages from 6 to 13 years and weights from 17 to 60 kg." | 9.08 | Pharmacokinetics of cefixime in children with urinary tract infections after a single oral dose. ( Kasteridou, N; Mamzoridi, K; Niopas, I; Peonides, A, 1996) |
| "A randomized controlled clinical study of cefetamet pivoxil (CAT) compared with cefixime (CFX) was conducted to evaluate its safety and efficacy in treating bacterial infections." | 9.08 | [A randomized controlled clinical study of cefetamet pivoxil versus cefixime in the treatment of 99 cases bacterial infections]. ( Hao, F; Li, J; Zhao, C, 1997) |
| "This double-blind randomized study compared 3-day regimens of cefixime (400 mg once daily) and ofloxacin (200 mg twice a day) in the treatment of urinary tract infections in women." | 9.07 | Double-blind study comparing 3-day regimens of cefixime and ofloxacin in treatment of uncomplicated urinary tract infections in women. ( Leshem, Y; Raz, R; Rottensterich, E; Tabenkin, H, 1994) |
| "In this 31-site multicenter trial, 565 adult patients with urinary tract infections were randomly assigned to receive either a 10-day course of cefixime 400 mg once daily (n = 279) or amoxicillin 250 mg three times daily (n = 286)." | 9.06 | A double-blind, multicenter, comparative study of the safety and efficacy of cefixime versus amoxicillin in the treatment of acute urinary tract infections in adult patients. ( Bryant, A; Iravani, A; Johnson, D; Richard, GA, 1988) |
| "One hundred six patients with acute, uncomplicated lower urinary tract infections participated in a randomized study that compared cefixime (one 400-mg tablet once daily) with trimethoprim (160 mg)/sulfamethoxazole (800 mg) (one tablet every 12 hours)." | 9.06 | Cefixime versus trimethoprim/sulfamethoxazole in treatment of patients with acute, uncomplicated lower urinary tract infections. ( Cox, CE, 1989) |
| "Cefixime (CFIX, Cefspan), a new oral cephem, was used in the treatment of urinary tract infections, and was evaluated for its therapeutic effectiveness and safety at the Department of Urology, Osaka Rosai Hospital." | 7.67 | [Clinical experience with cefixime in urinary tract infections]. ( Iwao, N; Kameoka, H; Miyoshi, S; Mizutani, S; Takano, Y, 1989) |
| "Cefixime is a new oral antibiotic with in vitro activity similar to that of parenteral third generation cephalosporins." | 6.66 | [Efficacy and tolerability of cefixime in urinary tract infections in adults. A French multicentric study]. ( Modai, J, 1989) |
| "Cefixime is a new orally active cephalosporin." | 6.66 | [Comparative study of intravenous ceftriaxone followed by oral cefixime versus ceftriaxone alone in the treatment of severe upper urinary tract infections]. ( Regnier, B, 1989) |
| "Cefixime is a third-generation oral cephalosporin that is highly active against a broad range of gram-negative and some gram-positive aerobic bacteria." | 6.41 | Cefixime in urinary tract infections with special reference to pediatrics: overview. ( Cataldi, L; Fanos, V, 2001) |
| "Cefixime is an oral third generation cephalosporin, frequently used in respiratory tract infections (RTI) in the pediatric population." | 5.15 | Clinical role of Cefixime in community-acquired infections. ( Aliu, A; Basha, N; Daka, A; Doda-Ejupi, T; Dreshaj, Sh; Geca, Nj; Kabashi, S; Mustafa, A; Shala, N; Tolaj, IQ, 2011) |
| " This study compares efficacy and safety of cefixime with amoxycillin + clavulanic acid in urinary tract infections." | 5.08 | [Comparative study of cefixime versus amoxicillin-clavulanic acid combination in the oral treatment of urinary tract infections in children]. ( Bost, C; Croizé, J; François, P; Wollschlager, K, 1995) |
| "The pharmacokinetics of cefixime, a third-generation broad-spectrum cephalosporin, were determined following administration of a 8 mg/kg single oral dose of cefixime suspension to six children with urinary tract infections, ages from 6 to 13 years and weights from 17 to 60 kg." | 5.08 | Pharmacokinetics of cefixime in children with urinary tract infections after a single oral dose. ( Kasteridou, N; Mamzoridi, K; Niopas, I; Peonides, A, 1996) |
| "A randomized controlled clinical study of cefetamet pivoxil (CAT) compared with cefixime (CFX) was conducted to evaluate its safety and efficacy in treating bacterial infections." | 5.08 | [A randomized controlled clinical study of cefetamet pivoxil versus cefixime in the treatment of 99 cases bacterial infections]. ( Hao, F; Li, J; Zhao, C, 1997) |
| "This double-blind randomized study compared 3-day regimens of cefixime (400 mg once daily) and ofloxacin (200 mg twice a day) in the treatment of urinary tract infections in women." | 5.07 | Double-blind study comparing 3-day regimens of cefixime and ofloxacin in treatment of uncomplicated urinary tract infections in women. ( Leshem, Y; Raz, R; Rottensterich, E; Tabenkin, H, 1994) |
| "The clinical and laboratory safety of cefixime based on analysis of data from 1575 adults (1118 treated daily and 457 treated twice a day) and 615 children (299 treated daily and 316 treated twice a day) in studies of urinary tract and lower and upper respiratory tract infections (including otitis media) is reviewed." | 5.06 | Safety profile of cefixime. ( Cartwright, K; Desjardins, RE; McCarthy, EF; Tally, FP, 1987) |
| "Cefixime (CFIX, Cefspan), a new oral cephem, was used in the treatment of urinary tract infections, and was evaluated for its therapeutic effectiveness and safety at the Department of Urology, Osaka University Hospital and 16 affiliated hospitals." | 5.06 | [Clinical evaluation of cefixime (CFIX) in the treatment of urinary tract infection]. ( Iwao, N; Kameoka, H; Matsuda, M; Miyoshi, S; Mizutani, S; Nakano, E; Sagawa, S; Sakurai, T; Sekii, K; Sonoda, T, 1989) |
| "In this 31-site multicenter trial, 565 adult patients with urinary tract infections were randomly assigned to receive either a 10-day course of cefixime 400 mg once daily (n = 279) or amoxicillin 250 mg three times daily (n = 286)." | 5.06 | A double-blind, multicenter, comparative study of the safety and efficacy of cefixime versus amoxicillin in the treatment of acute urinary tract infections in adult patients. ( Bryant, A; Iravani, A; Johnson, D; Richard, GA, 1988) |
| "One hundred six patients with acute, uncomplicated lower urinary tract infections participated in a randomized study that compared cefixime (one 400-mg tablet once daily) with trimethoprim (160 mg)/sulfamethoxazole (800 mg) (one tablet every 12 hours)." | 5.06 | Cefixime versus trimethoprim/sulfamethoxazole in treatment of patients with acute, uncomplicated lower urinary tract infections. ( Cox, CE, 1989) |
| "Thirty-five women with uncomplicated acute lower urinary tract infections proven by significant pre-treatment bacteriuria (> or = 10(5)CFU/ml) were treated with an oral dose of 100 mg cefixime twice a day for seven days." | 3.70 | In vitro activity and clinical evaluation of cefixime in urinary tract infection. ( Asvanich, K; Fugpholngam, V; Srimuang, S; Tanphaichitra, D, 1998) |
| "The aim of this study was to determine the prevalence of the microorganisms causing uncomplicated acute urinary tract infections in the community and their susceptibility to cefixime and another six antimicrobials in frequent use in Spain." | 3.70 | [Prevalence of urinary infections in the community and their susceptibility to cefixime]. ( Elía, S; Ferrer Ruscalleda, F; García Rodríguez, JA; García Sánchez, E, 1999) |
| "In a pilot study with a limited number of patients the efficacy and tolerance of cefixime, a new oral cephalosporin antibiotic, were investigated in 15 children with the clinical diagnosis of bacterial respiratory tract infection, otitis media or urinary tract infection." | 3.68 | [Therapy of pediatric infections with cefixime]. ( Helwig, H, 1990) |
| "Cefixime (CFIX, Cefspan), a new oral cephem, was used in the treatment of urinary tract infections, and was evaluated for its therapeutic effectiveness and safety at the Department of Urology, Osaka Rosai Hospital." | 3.67 | [Clinical experience with cefixime in urinary tract infections]. ( Iwao, N; Kameoka, H; Miyoshi, S; Mizutani, S; Takano, Y, 1989) |
| "The absorption and excretion and clinical effectiveness of cefixime (CFIX) granules, a new oral cephalosporin, were studied with pediatric patients with tonsillitis and urinary tract infection (UTI)." | 3.67 | [Clinical study on cefixime granules in the field of pediatrics]. ( Haruta, T; Kobayashi, Y; Kuroki, S, 1986) |
| "Cefixime (CFIX) was given orally to 25 children with acute bacterial infections including 13 with acute tonsillitis, 1 with acute tonsillitis and cervical lymphadenitis, 1 with acute bronchitis, 5 with bronchopneumonia and 5 with urinary tract infection." | 3.67 | [Clinical experience with cefixime in the pediatric field]. ( Aihara, R; Kobashi, H; Nishioka, A; Ohara, K; Okamoto, T, 1986) |
| "A clinical study of cefixime (CFIX), a new oral cephalosporin, was carried out to evaluate its therapeutic effectiveness on bacterial infections in children." | 3.67 | [Clinical studies on cefixime in pediatrics]. ( Endo, S; Hosoda, T; Masuda, M; Mimoto, H; Miyao, M; Tanaka, H; Yuasa, Y, 1986) |
| "Cefixime is a new orally active cephalosporin." | 2.66 | [Comparative study of intravenous ceftriaxone followed by oral cefixime versus ceftriaxone alone in the treatment of severe upper urinary tract infections]. ( Regnier, B, 1989) |
| "478/1063 patients were treated for urinary tract infections (upper or lower UTI) with 200 mg cefixime bid; clinical cure was obtained in 92 and 96 per cent of upper and lower UTI respectively, and bacteriological cure in 97." | 2.66 | [Efficacy and tolerability of cefixime in international and French studies]. ( Carbon, C, 1989) |
| "Cefixime is a new oral antibiotic with in vitro activity similar to that of parenteral third generation cephalosporins." | 2.66 | [Efficacy and tolerability of cefixime in urinary tract infections in adults. A French multicentric study]. ( Modai, J, 1989) |
| "Cefixime is a third-generation oral cephalosporin that is highly active against a broad range of gram-negative and some gram-positive aerobic bacteria." | 2.41 | Cefixime in urinary tract infections with special reference to pediatrics: overview. ( Cataldi, L; Fanos, V, 2001) |
| "We sought to describe the risk of recurrence at 1 month after the end of treatment for FUTI due to ESBL-E according to the oral relay therapy used." | 1.62 | Relay oral therapy in febrile urinary tract infections caused by extended spectrum beta-lactamase-producing Enterobacteriaceae in children: A French multicenter study. ( Andriantahina, I; Angoulvant, F; Birgy, A; Bonacorsi, S; Cixous, E; Cohen, R; Craiu, I; De Pontual, L; Dommergues, MA; Dubos, F; Gajdos, V; Georget, E; Gillet, Y; Grimprel, E; Jung, C; Launay, E; Levy, C; Lignieres, G; Madhi, F; Pinquier, D; Rybak, A; Soussan-Banini, V; Vignaud, O, 2021) |
| "Renal scarring (RS) was detected in 22 out of 70 patients with pyelonephritis following dimercaptosuccinic acid scan." | 1.48 | Antimicrobial misuse in pediatric urinary tract infections: recurrences and renal scarring. ( Jayaweera, JAAS; Reyes, M, 2018) |
| "Cefixime is a third-generation cephalosporin and is widely used in clinical practice in childhood." | 1.38 | Cefixime-induced oculogyric crisis. ( Bayram, E; Bayram, MT; Hiz, S; Turkmen, M, 2012) |
| "Cefixime activity was not adversely influenced by several important variables such as pH (over the range from 5 to 8), inoculum size (from 10(5) to 10(8) CFU per ml) and the presence of 50% human serum or urine." | 1.28 | Parameters characterizing the in vitro activity of cefixime, a new oral broad spectrum cephalosporin, against respiratory and urinary pathogens. ( Debbia, EA; Marchese, A; Pesce, A; Saverino, D; Schito, GC, 1992) |
| "Cefixime was poorly active against Gram-positive species, but was active (MIC90 less than 2 mg/l) against almost all the Gram-negative pathogens tested (except Pseudomonas aeruginosa), and particularly so against Klebsiella pneumoniae and members of the tribe Proteae." | 1.28 | Comparative in vitro activity of cefixime, cefaclor and loracarbef against urinary pathogens. ( Brumfitt, W; Hamilton-Miller, JM, 1991) |
| "Cefixime (CFIX) was administered orally in the treatment of 59 cases of urinary tract infection (UTI)." | 1.28 | [Treatment of urinary tract infection with cefixime]. ( Fujii, H; Fujisawa, M; Hashimoto, H; Inagaki, N; Miyata, M; Okamura, K; Sasaki, M; Yachiku, S; Yamaguchi, S; Yamauchi, K, 1989) |
| "86 hours and urinary excretions rates up to 12 hours after dosing were 16." | 1.27 | [Clinical studies of cefixime granules in pediatrics]. ( Chikaoka, H; Kamigaki, M; Koido, R; Matsumoto, K; Nakazawa, S; Narita, A; Niino, K; Sato, H; Suzuki, H, 1986) |
| "Twenty-one pediatric patients with bacterial infections (10, tonsillitis; 4, pharyngitis; and 7, urinary tract infections) were treated with CFIX at doses of 1." | 1.27 | [Fundamental and clinical studies on cefixime in the pediatric field]. ( Hakamada, S; Hayakawa, F; Kuno, K; Miyachi, Y; Nakashima, S; Nakashima, T, 1986) |
| "70 microgram/ml for a 3 mg/kg dosage and 2." | 1.27 | [Fundamental and clinical studies on cefixime in pediatrics]. ( Iwai, N; Katayama, M; Mizoguchi, F; Nakamura, H; Shibata, M, 1986) |
| "Cefixime (CFIX) was evaluated for pharmacokinetics, therapeutic effectiveness on infection, safety, and bacteriological effectiveness in pediatrics." | 1.27 | [Fundamental and clinical studies on cefixime in pediatric field]. ( Kida, K; Matsuda, H; Miyazaki, M; Murase, M, 1986) |
| "In 9 cases of respiratory infections, therapeutic results were excellent in 3 cases, good in 6 cases, and the effective rate was 100%." | 1.27 | [Fundamental and clinical studies of cefixime in children]. ( Nakayama, N; Tsuji, Y; Yanagishima, M, 1986) |
| " The mean half-life and the mean AUC values were 2." | 1.27 | [Pharmacokinetics and clinical effects of cefixime in pediatrics]. ( Ishimoto, K; Koga, T; Motohiro, T; Nagayama, K; Nishiyama, T; Shimada, Y; Tanaka, K; Tominaga, K; Tomita, S; Yamashita, F, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 26 (36.11) | 18.7374 |
| 1990's | 20 (27.78) | 18.2507 |
| 2000's | 9 (12.50) | 29.6817 |
| 2010's | 10 (13.89) | 24.3611 |
| 2020's | 7 (9.72) | 2.80 |
| Authors | Studies |
|---|---|
| Lignieres, G | 1 |
| Birgy, A | 2 |
| Jung, C | 2 |
| Bonacorsi, S | 2 |
| Levy, C | 2 |
| Angoulvant, F | 1 |
| Grimprel, E | 1 |
| Dommergues, MA | 2 |
| Gillet, Y | 1 |
| Craiu, I | 1 |
| Rybak, A | 1 |
| De Pontual, L | 1 |
| Dubos, F | 1 |
| Cixous, E | 1 |
| Gajdos, V | 2 |
| Pinquier, D | 2 |
| Andriantahina, I | 1 |
| Soussan-Banini, V | 1 |
| Georget, E | 1 |
| Launay, E | 2 |
| Vignaud, O | 1 |
| Cohen, R | 3 |
| Madhi, F | 3 |
| Tarawneh, O | 1 |
| Abu Mahfouz, H | 1 |
| Hamadneh, L | 1 |
| Deeb, AA | 1 |
| Al-Sheikh, I | 1 |
| Alwahsh, W | 1 |
| Fadhil Abed, A | 1 |
| Thelen, H | 3 |
| Dilworth, TJ | 3 |
| Mercier, RC | 3 |
| Mohapatra, S | 2 |
| Venugopal, SJ | 2 |
| Kalaivani, M | 2 |
| Kant, S | 2 |
| Tak, V | 2 |
| Panigrahy, R | 2 |
| Chunchanur, SK | 2 |
| Kocher, D | 2 |
| Behera, B | 2 |
| Pundir, S | 2 |
| Chaudhuri, S | 2 |
| Gautam, H | 2 |
| Sood, S | 2 |
| Das, BK | 2 |
| Kapil, A | 2 |
| Kumar, A | 2 |
| Kumari, R | 2 |
| Ambica, R | 2 |
| Hari, P | 2 |
| Malhotra, S | 2 |
| Salve, HR | 2 |
| Samanci, S | 1 |
| Pınarbaşı, AS | 1 |
| Boussetta, A | 1 |
| Kharbach, N | 1 |
| Abdellatif, A | 1 |
| Karray, A | 1 |
| Jellouli, M | 1 |
| Gargah, T | 1 |
| Cointe, A | 1 |
| Bidet, P | 1 |
| Hobson, CA | 1 |
| Bechet, S | 1 |
| Sobral, E | 1 |
| Vuthien, H | 1 |
| Ferroni, A | 1 |
| Aberrane, S | 1 |
| Cuzon, G | 1 |
| Beraud, L | 1 |
| Haas, H | 1 |
| Desmarest, M | 1 |
| Gökçe, İ | 1 |
| Çiçek, N | 1 |
| Güven, S | 1 |
| Altuntaş, Ü | 1 |
| Bıyıklı, N | 1 |
| Yıldız, N | 1 |
| Alpay, H | 1 |
| Jayaweera, JAAS | 1 |
| Reyes, M | 1 |
| Büyükcam, A | 1 |
| Liste, Ü | 1 |
| Bıçakçıgil, A | 1 |
| Kara, A | 1 |
| Sancak, B | 1 |
| Sarikaya Solak, S | 1 |
| Ficicioglu, S | 1 |
| Wolff, N | 1 |
| Indaburu, I | 1 |
| Muller, F | 1 |
| Mariescu Depaire, N | 1 |
| Demir, T | 1 |
| Dadali, M | 1 |
| Nateghian, AR | 1 |
| Robinson, JL | 1 |
| Mohandessi, S | 1 |
| Hooman, N | 1 |
| Finnell, SM | 1 |
| Carroll, AE | 1 |
| Downs, SM | 1 |
| Bayram, E | 1 |
| Bayram, MT | 1 |
| Hiz, S | 1 |
| Turkmen, M | 1 |
| Dreshaj, Sh | 1 |
| Doda-Ejupi, T | 1 |
| Tolaj, IQ | 1 |
| Mustafa, A | 1 |
| Kabashi, S | 1 |
| Shala, N | 1 |
| Geca, Nj | 1 |
| Aliu, A | 1 |
| Daka, A | 1 |
| Basha, N | 1 |
| Biscardi, S | 1 |
| Bingen, E | 1 |
| Jaby, O | 1 |
| Epaud, R | 1 |
| Noorbakhsh, S | 1 |
| Lari, AR | 1 |
| Masjedian, F | 1 |
| Mostafavi, H | 1 |
| Alaghehbandan, R | 1 |
| Carcía-Rodriguez, JA | 1 |
| García-Sanchez, JE | 1 |
| García-Garcia, MI | 1 |
| García-Sanchez, E | 1 |
| Munõz-Bellido, JL | 1 |
| Trujillano, I | 1 |
| Capparelli, FJ | 1 |
| Diaz, MF | 1 |
| Hlavnika, A | 1 |
| Wainsztein, NA | 1 |
| Leiguarda, R | 1 |
| Del Castillo, ME | 1 |
| Kumamoto, Y | 1 |
| Tsukamoto, T | 1 |
| Matsukawa, M | 1 |
| Kunishima, Y | 1 |
| Hirose, T | 1 |
| Shigeta, S | 1 |
| Yamaguti, O | 1 |
| Ishibashi, K | 1 |
| Suzutani, T | 1 |
| Yoshida, H | 1 |
| Imafuku, Y | 1 |
| Murai, M | 1 |
| Watanabe, K | 1 |
| Kobayashi, Y | 2 |
| Uchida, H | 1 |
| Matsuda, S | 1 |
| Sato, S | 1 |
| Fujime, M | 1 |
| Fujita, K | 1 |
| Igari, J | 1 |
| Oguri, T | 1 |
| Yamaguchi, K | 1 |
| Furuya, N | 1 |
| Deguchi, T | 1 |
| Ishihara, S | 1 |
| Ooe, H | 1 |
| Oka, T | 1 |
| Kitamura, M | 1 |
| Fukuhara, Y | 1 |
| Kamidono, S | 1 |
| Arakawa, S | 1 |
| Kumon, H | 1 |
| Monden, K | 1 |
| Matsumoto, T | 1 |
| Muratani, T | 1 |
| Naito, S | 1 |
| Egashira, T | 1 |
| Konishi, T | 1 |
| Kohno, S | 1 |
| Hirakata, Y | 1 |
| Kondo, A | 1 |
| Matsuda, J | 1 |
| Nakano, M | 1 |
| François, P | 1 |
| Croizé, J | 1 |
| Bost, C | 1 |
| Wollschlager, K | 1 |
| Pascual, A | 1 |
| Martínez-Martínez, L | 1 |
| García-Gestoso, ML | 1 |
| Romero, J | 1 |
| Raz, R | 2 |
| Rottensterich, E | 1 |
| Leshem, Y | 1 |
| Tabenkin, H | 1 |
| Sereda, EV | 1 |
| Gusel', VA | 1 |
| Feshchenko, IuI | 1 |
| Ustinovich, AK | 1 |
| Zubovich, VK | 1 |
| Trofimov, VI | 1 |
| Nedostup, AV | 1 |
| Ovchinnikov, IuM | 1 |
| Pluzhnikov, MS | 1 |
| Darenkov, AF | 1 |
| Mamzoridi, K | 1 |
| Kasteridou, N | 1 |
| Peonides, A | 1 |
| Niopas, I | 1 |
| Asvanich, K | 1 |
| Fugpholngam, V | 1 |
| Srimuang, S | 1 |
| Tanphaichitra, D | 1 |
| García-Rodríguez, JA | 1 |
| Ludwig, E | 1 |
| Ferrer Ruscalleda, F | 1 |
| Elía, S | 1 |
| García Sánchez, E | 1 |
| García Rodríguez, JA | 1 |
| Hoberman, A | 1 |
| Wald, ER | 1 |
| Hickey, RW | 1 |
| Baskin, M | 1 |
| Charron, M | 1 |
| Majd, M | 1 |
| Kearney, DH | 1 |
| Reynolds, EA | 1 |
| Ruley, J | 1 |
| Janosky, JE | 1 |
| Zhao, C | 1 |
| Li, J | 1 |
| Hao, F | 1 |
| Ogle, JW | 1 |
| Reed, K | 1 |
| Newton, W | 1 |
| Pomeranz, A | 2 |
| El-Khayam, A | 1 |
| Korzets, Z | 1 |
| Kessler, OJ | 1 |
| Godfrey, L | 1 |
| Katz, B | 1 |
| Wolach, B | 2 |
| Fanos, V | 1 |
| Cataldi, L | 1 |
| Hamilton-Miller, JM | 2 |
| Gok, F | 1 |
| Duzova, A | 1 |
| Baskin, E | 1 |
| Ozen, S | 1 |
| Besbas, N | 1 |
| Bakkaloglu, A | 1 |
| Ho, MW | 1 |
| Wang, FD | 1 |
| Fung, CP | 1 |
| Liu, CY | 1 |
| Debbia, EA | 1 |
| Marchese, A | 1 |
| Pesce, A | 1 |
| Saverino, D | 1 |
| Schito, GC | 1 |
| Dagan, R | 1 |
| Einhorn, M | 1 |
| Lang, R | 1 |
| Miron, D | 1 |
| Weinstock, A | 1 |
| Steinberger, J | 1 |
| Weintraub, A | 1 |
| Di Nola, F | 1 |
| Arione, R | 1 |
| Bramato, C | 1 |
| Brumfitt, W | 1 |
| Naber, KG | 1 |
| Helwig, H | 1 |
| McCarthy, M | 1 |
| Aarons, D | 1 |
| Scott, HV | 1 |
| Modai, J | 1 |
| Regnier, B | 1 |
| Carbon, C | 1 |
| Kameoka, H | 2 |
| Takano, Y | 1 |
| Miyoshi, S | 2 |
| Iwao, N | 2 |
| Mizutani, S | 2 |
| Sonoda, T | 1 |
| Matsuda, M | 1 |
| Nakano, E | 1 |
| Sagawa, S | 1 |
| Sekii, K | 1 |
| Sakurai, T | 1 |
| Cox, CE | 1 |
| Mikawa, H | 1 |
| Mayumi, M | 1 |
| Akiyama, Y | 1 |
| Ito, S | 1 |
| Watanabe, Y | 1 |
| Kanaoka, H | 1 |
| Takeshita, S | 1 |
| Takahashi, Y | 1 |
| Akiyama, F | 1 |
| Yoshimura, T | 1 |
| Fujisawa, M | 1 |
| Sasaki, M | 1 |
| Fujii, H | 1 |
| Okamura, K | 1 |
| Miyata, M | 1 |
| Hashimoto, H | 1 |
| Yachiku, S | 1 |
| Yamauchi, K | 1 |
| Yamaguchi, S | 1 |
| Inagaki, N | 1 |
| Iravani, A | 1 |
| Richard, GA | 1 |
| Johnson, D | 1 |
| Bryant, A | 1 |
| Tally, FP | 1 |
| Desjardins, RE | 1 |
| McCarthy, EF | 1 |
| Cartwright, K | 1 |
| Levenstein, J | 1 |
| Summerfield, PJ | 1 |
| Fourie, S | 1 |
| Brink, G | 1 |
| Michaelides, B | 1 |
| Murray, E | 1 |
| Naidoo, N | 1 |
| Meguro, H | 1 |
| Arimasu, O | 1 |
| Sohda, H | 1 |
| Yoshida, J | 1 |
| Togasaki, K | 1 |
| Fujii, R | 1 |
| Nakazawa, S | 2 |
| Sato, H | 1 |
| Narita, A | 1 |
| Suzuki, H | 1 |
| Matsumoto, K | 1 |
| Chikaoka, H | 1 |
| Kamigaki, M | 1 |
| Koido, R | 1 |
| Niino, K | 1 |
| Sunakawa, K | 1 |
| Saito, N | 1 |
| Ishizuka, Y | 1 |
| Iwata, S | 1 |
| Kumagai, N | 1 |
| Yokota, T | 1 |
| Asaishi, T | 1 |
| Kusano, S | 1 |
| Sato, Y | 1 |
| Kusumoto, Y | 1 |
| Toyonaga, Y | 1 |
| Sugita, M | 1 |
| Nakamura, H | 2 |
| Joh, K | 1 |
| Takahashi, T | 1 |
| Kurosu, Y | 1 |
| Hori, M | 1 |
| Nakashima, S | 1 |
| Hayakawa, F | 1 |
| Nakashima, T | 1 |
| Miyachi, Y | 1 |
| Hakamada, S | 1 |
| Kuno, K | 1 |
| Iwai, N | 1 |
| Shibata, M | 1 |
| Mizoguchi, F | 1 |
| Katayama, M | 1 |
| Haruta, T | 1 |
| Kuroki, S | 1 |
| Furukawa, S | 1 |
| Okada, T | 1 |
| Aihara, R | 1 |
| Kobashi, H | 1 |
| Nishioka, A | 1 |
| Ohara, K | 1 |
| Okamoto, T | 1 |
| Hosoda, T | 1 |
| Masuda, M | 1 |
| Miyao, M | 1 |
| Mimoto, H | 1 |
| Endo, S | 1 |
| Yuasa, Y | 1 |
| Tanaka, H | 1 |
| Kurashige, T | 1 |
| Morita, H | 1 |
| Araki, K | 1 |
| Ogura, H | 1 |
| Morioka, N | 1 |
| Kitamura, I | 1 |
| Miyazaki, M | 1 |
| Kida, K | 1 |
| Matsuda, H | 1 |
| Murase, M | 1 |
| Nakayama, N | 1 |
| Yanagishima, M | 1 |
| Tsuji, Y | 1 |
| Motohiro, T | 1 |
| Tanaka, K | 1 |
| Koga, T | 1 |
| Shimada, Y | 1 |
| Tomita, S | 1 |
| Nishiyama, T | 1 |
| Ishimoto, K | 1 |
| Tominaga, K | 1 |
| Yamashita, F | 1 |
| Nagayama, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Bladder Stimulation Technique on Urine Specimen Collection in Newborns: A Randomized Controlled Study[NCT05416736] | 64 participants (Actual) | Interventional | 2021-10-15 | Completed | |||
| Evaluation of the Effectiveness of Antibiotic Prophylaxis in Children With a History of Upper Urinary Tract Infections:a Multicentre Randomised Study[NCT00156546] | Phase 4 | 660 participants | Interventional | 2000-05-31 | Active, not recruiting | ||
| A Multicenter Randomized Controlled Trial of Antibiotic Treatment in Children With Urinary Tract Infections: Oral Amoxicillin/Clavulanic Acid vs Initial iv Ceftriaxone.[NCT00161330] | Phase 3 | 440 participants | Interventional | 2000-06-30 | Terminated | ||
| Efficacy of the Application of Moxifloxacin and Cefixime in Reduction of Inflammatory Sequelae and Complications After Mandibular Third Molar Surgery[NCT05027893] | 157 participants (Actual) | Interventional | 2019-06-07 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for cefixime and Urinary Tract Infections
| Article | Year |
|---|---|
Cephalosporin-induced linear IgA dermatosis in a child: Case report and literature review.
Topics: Anti-Bacterial Agents; Cefixime; Child, Preschool; Drug Eruptions; Female; Humans; Linear IgA Bullou | 2019 |
Technical report—Diagnosis and management of an initial UTI in febrile infants and young children.
Topics: Antibiotic Prophylaxis; Cefixime; Fever; Humans; Infant; Prevalence; Pyelonephritis; Radiography; Re | 2011 |
Cefixime in urinary tract infections with special reference to pediatrics: overview.
Topics: Bacterial Infections; Cefixime; Cephalosporins; Child; Child, Preschool; Humans; Infant; Urinary Tra | 2001 |
Overview of cefixime use in community-acquired infections.
Topics: Cefixime; Cephalosporins; Community-Acquired Infections; Escherichia coli Infections; Female; Haemop | 2000 |
[Cefixime. Microbiologic, kinetic and clinical profile].
Topics: Animals; Bacteria; Cefixime; Cefotaxime; Gonorrhea; Humans; Microbial Sensitivity Tests; Otitis Medi | 1991 |
[Cefixime in urinary tract infections. (Specific studies and literature review)].
Topics: Anti-Infective Agents, Urinary; Cefixime; Cefotaxime; Enterobacteriaceae Infections; Humans; Urinary | 1990 |
21 trials available for cefixime and Urinary Tract Infections
| Article | Year |
|---|---|
Clinical role of Cefixime in community-acquired infections.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Child; Child, Preschool; Community-Acquired Infe | 2011 |
Comparison of intravenous aminoglycoside therapy with switch therapy to cefixime in urinary tract infections.
Topics: Adolescent; Age Factors; Aminoglycosides; Cefixime; Cefotaxime; Child; Child, Preschool; Dose-Respon | 2004 |
[Comparative study of cefixime versus amoxicillin-clavulanic acid combination in the oral treatment of urinary tract infections in children].
Topics: Administration, Oral; Adolescent; Amoxicillin; Anti-Bacterial Agents; Cefixime; Cefotaxime; Child; C | 1995 |
Double-blind study comparing 3-day regimens of cefixime and ofloxacin in treatment of uncomplicated urinary tract infections in women.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Cefixime; Cefotaxime; Double-Blin | 1994 |
[Clinical efficacy of cefixime (results of multicenter trials)].
Topics: Adolescent; Adult; Anti-Infective Agents; Cefixime; Cefotaxime; Child; Child, Preschool; Humans; Inf | 1993 |
Pharmacokinetics of cefixime in children with urinary tract infections after a single oral dose.
Topics: Adolescent; Adult; Area Under Curve; Cefixime; Cefotaxime; Cephalosporins; Child; Chromatography, Hi | 1996 |
Cefixime in the treatment of respiratory and urinary tract infections.
Topics: Adult; Cefixime; Cefotaxime; Cephalosporins; Child; Humans; Otitis Media; Pneumococcal Infections; R | 1998 |
Oral versus initial intravenous therapy for urinary tract infections in young febrile children.
Topics: Acute Disease; Administration, Oral; Cefixime; Cefotaxime; Cephalosporins; Cost-Benefit Analysis; Fe | 1999 |
Oral versus initial intravenous therapy for urinary tract infections in young febrile children.
Topics: Acute Disease; Administration, Oral; Cefixime; Cefotaxime; Cephalosporins; Cost-Benefit Analysis; Fe | 1999 |
Oral versus initial intravenous therapy for urinary tract infections in young febrile children.
Topics: Acute Disease; Administration, Oral; Cefixime; Cefotaxime; Cephalosporins; Cost-Benefit Analysis; Fe | 1999 |
Oral versus initial intravenous therapy for urinary tract infections in young febrile children.
Topics: Acute Disease; Administration, Oral; Cefixime; Cefotaxime; Cephalosporins; Cost-Benefit Analysis; Fe | 1999 |
[A randomized controlled clinical study of cefetamet pivoxil versus cefixime in the treatment of 99 cases bacterial infections].
Topics: Adolescent; Adult; Bacterial Infections; Cefixime; Cefotaxime; Ceftizoxime; Cephalosporins; Escheric | 1997 |
Comparative study of cefixime alone versus intramuscular ceftizoxime followed by cefixime in the treatment of urinary tract infections in children.
Topics: Adolescent; Cefixime; Ceftizoxime; Child; Child, Preschool; Drug Administration Routes; Female; Gram | 2001 |
Comparative study of ceftibuten and cefixime in the treatment of complicated urinary tract infections.
Topics: Adult; Aged; Aged, 80 and over; Cefixime; Ceftibuten; Cephalosporins; Enterobacteriaceae; Enterobact | 2001 |
Once daily cefixime compared with twice daily trimethoprim/sulfamethoxazole for treatment of urinary tract infection in infants and children.
Topics: Administration, Oral; Anti-Infective Agents, Urinary; Cefixime; Cefotaxime; Child; Child, Preschool; | 1992 |
[Efficacy and tolerability of cefixime in urinary tract infections in adults. A French multicentric study].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefixime; Cefotaxime; Clinical Trials as Topic; Female; | 1989 |
[Comparative study of intravenous ceftriaxone followed by oral cefixime versus ceftriaxone alone in the treatment of severe upper urinary tract infections].
Topics: Administration, Oral; Cefixime; Cefotaxime; Ceftriaxone; Clinical Trials as Topic; Female; Follow-Up | 1989 |
[Efficacy and tolerability of cefixime in international and French studies].
Topics: Cefixime; Cefotaxime; Clinical Trials as Topic; Gastrointestinal Diseases; Humans; Multicenter Studi | 1989 |
[Clinical evaluation of cefixime (CFIX) in the treatment of urinary tract infection].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Cefixime; Cefotaxime; Child; Clini | 1989 |
Cefixime versus trimethoprim/sulfamethoxazole in treatment of patients with acute, uncomplicated lower urinary tract infections.
Topics: Anti-Infective Agents, Urinary; Cefixime; Cefotaxime; Drug Administration Schedule; Escherichia coli | 1989 |
[Clinical studies on cefixime in pediatrics].
Topics: Adolescent; Bacterial Infections; Bronchitis; Cefixime; Cefotaxime; Child; Child, Preschool; Drug Ev | 1989 |
A double-blind, multicenter, comparative study of the safety and efficacy of cefixime versus amoxicillin in the treatment of acute urinary tract infections in adult patients.
Topics: Acute Disease; Adolescent; Adult; Aged; Amoxicillin; Cefixime; Cefotaxime; Clinical Trials as Topic; | 1988 |
Safety profile of cefixime.
Topics: Adult; Cefixime; Cefotaxime; Child; Child, Preschool; Clinical Trials as Topic; Diarrhea; Drug Admin | 1987 |
Comparison of cefixime and co-trimoxazole in acute uncomplicated urinary tract infection. A double-blind general practice study.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefixime; Cefotaxime; Clinical Trials as Topic; Double-Blind Met | 1986 |
45 other studies available for cefixime and Urinary Tract Infections
| Article | Year |
|---|---|
Relay oral therapy in febrile urinary tract infections caused by extended spectrum beta-lactamase-producing Enterobacteriaceae in children: A French multicenter study.
Topics: Administration, Oral; Adolescent; Amoxicillin-Potassium Clavulanate Combination; beta-Lactamases; Ce | 2021 |
Assessment of persistent antimicrobial and anti-biofilm activity of p-HEMA hydrogel loaded with rifampicin and cefixime.
Topics: Anti-Bacterial Agents; Biofilms; Cefixime; Female; HEK293 Cells; Humans; Hydrogels; Male; Methacryla | 2022 |
Examining the Combination of Cefixime and Amoxicillin/Clavulanate against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Isolates.
Topics: Amoxicillin-Potassium Clavulanate Combination; beta-Lactamases; Cefixime; Escherichia coli; Escheric | 2022 |
Examining the Combination of Cefixime and Amoxicillin/Clavulanate against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Isolates.
Topics: Amoxicillin-Potassium Clavulanate Combination; beta-Lactamases; Cefixime; Escherichia coli; Escheric | 2022 |
Examining the Combination of Cefixime and Amoxicillin/Clavulanate against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Isolates.
Topics: Amoxicillin-Potassium Clavulanate Combination; beta-Lactamases; Cefixime; Escherichia coli; Escheric | 2022 |
Examining the Combination of Cefixime and Amoxicillin/Clavulanate against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Isolates.
Topics: Amoxicillin-Potassium Clavulanate Combination; beta-Lactamases; Cefixime; Escherichia coli; Escheric | 2022 |
Examining the Combination of Cefixime and Amoxicillin/Clavulanate against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Isolates.
Topics: Amoxicillin-Potassium Clavulanate Combination; beta-Lactamases; Cefixime; Escherichia coli; Escheric | 2022 |
Examining the Combination of Cefixime and Amoxicillin/Clavulanate against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Isolates.
Topics: Amoxicillin-Potassium Clavulanate Combination; beta-Lactamases; Cefixime; Escherichia coli; Escheric | 2022 |
Examining the Combination of Cefixime and Amoxicillin/Clavulanate against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Isolates.
Topics: Amoxicillin-Potassium Clavulanate Combination; beta-Lactamases; Cefixime; Escherichia coli; Escheric | 2022 |
Examining the Combination of Cefixime and Amoxicillin/Clavulanate against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Isolates.
Topics: Amoxicillin-Potassium Clavulanate Combination; beta-Lactamases; Cefixime; Escherichia coli; Escheric | 2022 |
Examining the Combination of Cefixime and Amoxicillin/Clavulanate against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Isolates.
Topics: Amoxicillin-Potassium Clavulanate Combination; beta-Lactamases; Cefixime; Escherichia coli; Escheric | 2022 |
Antibiotic resistance of uropathogens among the community-dwelling pregnant and nonpregnant female: a step towards antibiotic stewardship.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antimicrobial Stewardship; Bac | 2022 |
Antibiotic resistance of uropathogens among the community-dwelling pregnant and nonpregnant female: a step towards antibiotic stewardship.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antimicrobial Stewardship; Bac | 2022 |
Antibiotic resistance of uropathogens among the community-dwelling pregnant and nonpregnant female: a step towards antibiotic stewardship.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antimicrobial Stewardship; Bac | 2022 |
Antibiotic resistance of uropathogens among the community-dwelling pregnant and nonpregnant female: a step towards antibiotic stewardship.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antimicrobial Stewardship; Bac | 2022 |
Microbial etiology and antibiotic resistance in urinary tract infections in children; view from an area where antibiotics are overused.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Cefix | 2023 |
Predictive factors of urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli in children: a prospective Tunisian study.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefixime; Child; Child, Preschool; Escherichia coli; Female; | 2023 |
Clavulanate combinations with mecillinam, cefixime or cefpodoxime against ESBL-producing Enterobacterales frequently associated with blaOXA-1 in a paediatric population with febrile urinary tract infections.
Topics: Amdinocillin; Anti-Bacterial Agents; Cefixime; Cefpodoxime; Ceftizoxime; Child; Clavulanic Acid; Hum | 2021 |
Changes in Bacterial Resistance Patterns of Pediatric Urinary Tract Infections and Rationale for Empirical Antibiotic Therapy.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Cefazo | 2017 |
Antimicrobial misuse in pediatric urinary tract infections: recurrences and renal scarring.
Topics: Anti-Bacterial Agents; Biofilms; Cefixime; Child; Child, Preschool; Cicatrix; Escherichia coli; Esch | 2018 |
A case of Raoultella ornithinolytica urinary tract infection in a pediatric patient.
Topics: Anti-Bacterial Agents; Cefixime; Child; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacter | 2019 |
[Purple urine bag syndrome…].
Topics: Aged, 80 and over; Anti-Bacterial Agents; Catheters, Indwelling; Cefixime; Color; Drainage; Female; | 2013 |
Recurrent complicated urinary tract infection due to rare pathogen Sphingomonas paucimobilis: contamination or real deal?
Topics: Anti-Bacterial Agents; Cefixime; Community-Acquired Infections; Diabetes Mellitus, Type 1; Diabetic | 2016 |
Resistance pattern of breakthrough urinary tract infections in children on antibiotic prophylaxis.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Cefixime; Child; Child, Preschool | 2009 |
Cefixime-induced oculogyric crisis.
Topics: Anti-Bacterial Agents; Attention Deficit Disorder with Hyperactivity; Cefixime; Child; Dopamine Anta | 2012 |
Combined relay therapy with oral cefixime and clavulanate for febrile urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli.
Topics: Administration, Oral; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cefixime; Chil | 2013 |
Cefixime versus cefotaxime against gram-negative bacteria causing urinary tract infections.
Topics: Anti-Bacterial Agents; Cefixime; Cefotaxime; Gram-Negative Bacteria; Humans; Microbial Sensitivity T | 1989 |
Cefepime- and cefixime-induced encephalopathy in a patient with normal renal function.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Brain; Cefepime; Cefixime; Cephalosporins; Confusion; Cons | 2005 |
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
Topics: Aminoglycosides; Ampicillin; Anti-Infective Agents; Aztreonam; Cefixime; Cefozopran; Cefpirome; Cefp | 2006 |
Urinary tract infection caused by quinolone-resistant Campylobacter coli.
Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Cefixime; Cefotaxime; Female; H | 1994 |
In vitro activity and clinical evaluation of cefixime in urinary tract infection.
Topics: Adult; Aged; Cefixime; Cefotaxime; Cephalosporins; Drug Administration Schedule; Female; Humans; Mic | 1998 |
Bacteriological comparison of cefixime in patients with noncomplicated urinary tract infection in Spain. Preliminary results.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefixime; Cefotaxime; Cephalosporins; Clavulanic Acid; Drug Resi | 1998 |
[Prevalence of urinary infections in the community and their susceptibility to cefixime].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefixime; Cephalosporins; Cross-Sectional Studies; Drug | 1999 |
Antimicrobial therapy for ambulatory pediatrics.
Topics: Ambulatory Care; Anti-Bacterial Agents; Anti-Infective Agents; Cefixime; Cefuroxime; Cephalexin; Cep | 1999 |
Oral or IV antibiotics for the treatment of febrile children with UTIs?
Topics: Administration, Oral; Anti-Infective Agents, Urinary; Cefixime; Cefotaxime; Cephalosporins; Child, P | 1999 |
A bioassay evaluation of the urinary antibacterial efficacy of low dose prophylactic antibiotics in children with vesicoureteral reflux.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Biological Assay; Cefixime; Cephalexin; Child; Child, | 2000 |
Parameters characterizing the in vitro activity of cefixime, a new oral broad spectrum cephalosporin, against respiratory and urinary pathogens.
Topics: Anti-Infective Agents, Urinary; Cefixime; Cefotaxime; Drug Interactions; Enterobacteriaceae; Gram-Ne | 1992 |
Comparative in vitro activity of cefixime, cefaclor and loracarbef against urinary pathogens.
Topics: Anti-Infective Agents, Urinary; Bacteria; Cefaclor; Cefixime; Cefotaxime; Cephalosporins; Humans; Mi | 1991 |
[Therapy of pediatric infections with cefixime].
Topics: Anti-Infective Agents; Bronchitis; Cefixime; Cefotaxime; Child; Child, Preschool; Humans; Lymphadeni | 1990 |
Cefixime: in vitro sensitivity of respiratory and urinary tract infection organisms.
Topics: Anti-Bacterial Agents; Cefixime; Cefotaxime; Humans; Microbial Sensitivity Tests; Respiratory Tract | 1990 |
[Clinical experience with cefixime in urinary tract infections].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefixime; Cefotaxime; Cystitis; Dr | 1989 |
[Treatment of urinary tract infection with cefixime].
Topics: Anti-Infective Agents, Urinary; Cefixime; Cefotaxime; Drug Evaluation; Escherichia coli Infections; | 1989 |
[Clinical evaluation of cefixime in children].
Topics: Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Haemophilus Infections; | 1986 |
[Clinical studies of cefixime granules in pediatrics].
Topics: Administration, Oral; Bacterial Infections; Capsules; Cefixime; Cefotaxime; Child; Child, Preschool; | 1986 |
[Fundamental and clinical studies of cefixime granules in pediatrics].
Topics: Adolescent; Bacteria; Bacterial Infections; Capsules; Cefixime; Cefotaxime; Child; Child, Preschool; | 1986 |
[Fundamental and clinical studies on cefixime (5% granules) in the pediatric field].
Topics: Administration, Oral; Bacteria; Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; | 1986 |
[Fundamental and clinical studies on cefixime in the pediatric field].
Topics: Acute Disease; Bacteria; Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; Female | 1986 |
[Fundamental and clinical studies on cefixime in pediatrics].
Topics: Bacteria; Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Humans; Infan | 1986 |
[Clinical study on cefixime granules in the field of pediatrics].
Topics: Administration, Oral; Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; Female; H | 1986 |
[Clinical experience with cefixime in the pediatric infections].
Topics: Acute Disease; Adolescent; Bronchitis; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Half-L | 1986 |
[Clinical experience with cefixime in the pediatric field].
Topics: Acute Disease; Adolescent; Bacterial Infections; Bronchopneumonia; Cefixime; Cefotaxime; Child; Chil | 1986 |
[Clinical studies on cefixime in pediatrics].
Topics: Bacteria; Bacterial Infections; Cefixime; Cefotaxime; Chemical and Drug Induced Liver Injury; Child; | 1986 |
[Fundamental and clinical studies on cefixime in pediatrics].
Topics: Administration, Oral; Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; Female; H | 1986 |
[Fundamental and clinical studies on cefixime in pediatric field].
Topics: Acute Disease; Bacterial Infections; Cefixime; Cefotaxime; Child; Child, Preschool; Enteritis; Femal | 1986 |
[Fundamental and clinical studies of cefixime in children].
Topics: Administration, Oral; Adolescent; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Humans; Inf | 1986 |
[Pharmacokinetics and clinical effects of cefixime in pediatrics].
Topics: Acute Disease; Adolescent; Bacterial Infections; Bronchitis; Cefixime; Cefotaxime; Child; Child, Pre | 1986 |